C02AB Methyldopa, centrally acting adntiadrenergic agents
ATC group of level 4 – chemical subgroup · in plain English: medicines for high blood pressure
This site has the patient leaflet or the SPC of 16 medicines in this group and its subgroups.
- 13 prescription only (POM)
- 3 no longer supplied or not available
Active substance: Methyldopa – all medicines with this substance, also in combinations.
Place in the ATC classification
- C Cardiovascular system drugs 1,712 medicines
- C02 Antihypertensives 133 medicines
- C02A Antiadrenergic agents, centrally acting 48 medicines
-
C02AB Methyldopa, centrally acting adntiadrenergic agents 16 medicines
- C02AB01 methyldopa (levorotatory) 16 medicines
-
C02AB Methyldopa, centrally acting adntiadrenergic agents 16 medicines
- C02A Antiadrenergic agents, centrally acting 48 medicines
- C02 Antihypertensives 133 medicines
1 more subgroup has no medicine with a leaflet on this site.
Medicines in the group and its subgroups
Other groups of the same level
- C02AC Imidazoline receptor agonists 32 medicines
Other names of the ATC group
- Czech: C02AB Methyldopa
- French: C02AB méthyldopa
- German: C02AB Methyldopa
- Spanish: C02AB Metildopa (antihipertensivos)
- German: C02AB Methyldopa
- Italian: C02AB Metildopa
- Polish: C02AB Metylodopa
- Turkish: C02AB Metildopa, merkezi etkili adntiadrenerjik ajanlar
- Portuguese (Brazil): C02AB Metildopa
- Slovak: C02AB Metyldopa
- German (Switzerland): C02AB Methyldopa
- French (Switzerland): C02AB Méthyldopa
- Italian (Switzerland): C02AB Metildopa
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group C02AB
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.